Cara Therapeutics | CARA - Passivo Circulante





Passivo Circulante Alterar Data
Acadia Pharmaceuticals USD 305.52M 28.41M 2026-03
Alterity Therapeutics Limited AUD 1.73M 2.77M 2025-12
Cara Therapeutics USD 11.04M 2K 2025-12
Cassava Sciences USD 40.11M 3.72M 2026-03
Chugai Pharma JPY 327.7B 83.38B 2026-03
Cipla INR 70.14B 7.16B 2026-03
Clal Biotechnology ILS 6.66M 3.75M 2023-12
Compugen USD 22.04M 533K 2026-03
CSL USD 4.61B 207M 2025-12
Grifols EUR 2.37B 156.97M 2025-12
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
J&J USD 57.72B 3.59B 2026-03
Neurocrine Biosciences USD 831.7M 88.3M 2026-03
Pacira USD 108.79M 11.8M 2026-03
Pfizer USD 34.35B 2.64B 2026-03
RedHill Biopharma USD 19.22M 3.07M 2025-12
Supernus Pharmaceuticals USD 373.93M 35.76M 2026-03
Vanda Pharmaceuticals USD 145.16M 27.29M 2025-12